Comparison of Digoxin and Ivabradine in Heart Failure With Preserved Systolic Function. Time to Rethink About Digoxin.

Trial Profile

Comparison of Digoxin and Ivabradine in Heart Failure With Preserved Systolic Function. Time to Rethink About Digoxin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Nov 2015

At a glance

  • Drugs Digoxin (Primary) ; Ivabradine (Primary)
  • Indications Atrial fibrillation; Heart failure
  • Focus Therapeutic Use
  • Acronyms DIGandIVA
  • Most Recent Events

    • 19 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top